Sökning: onr:"swepub:oai:DiVA.org:uu-419795" > Post-Discharge Blee...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06082naa a2200553 4500 | |
001 | oai:DiVA.org:uu-419795 | |
003 | SwePub | |
008 | 200916s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4197952 URI |
024 | 7 | a https://doi.org/10.1016/j.jacc.2020.05.0312 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Marquis-Gravel, Guillaumeu Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.4 aut |
245 | 1 0 | a Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI |
264 | 1 | b Elsevier BV,c 2020 |
338 | a print2 rdacarrier | |
520 | a BACKGROUND The long-term prognostic impact of post-discharge bleeding in the unique population of patients with acute coronary syndrome (ACS) treated without percutaneous coronary intervention (PCI) remains unexplored.OBJECTIVES The aim of this study was to assess the association between post-discharge bleeding and subsequent mortality after ACS according to index strategy (PCI or no PCI) and to contrast with the association between post-discharge myocardial infarction (MI) and subsequent mortality.METHODS In a harmonized dataset of 4 multicenter randomized trials (APPRAISE-2 [Apixaban for Prevention of Acute Ischemic Events-2], PLATO [Study of Platelet Inhibition and Patient Outcomes], TRACER [Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome], and TRILOGY ACS [Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes]), the association between post-discharge noncoronary artery bypass graft-related GUSTO (Global Use of Strategies to Open Occluded Coronary Arteries) moderate, severe, or life-threatening bleeding (landmark 7 days post-ACS) and subsequent all-cause mortality was evaluated in a time-updated Cox proportional hazards analysis. Interaction with index treatment strategy was assessed. Results were contrasted with risk for mortality following post-discharge MI.RESULTS Among 45,011 participants, 1,133 experienced post-discharge bleeding events (2.6 per 100 patient-years), and 2,149 died during follow-up. The risk for mortality was significantly higher <30 days (adjusted hazard ratio: 15.7; 95% confidence interval: 12.3 to 20.0) and 30 days to 12 months (adjusted hazard ratio: 2.7; 95% confidence interval: 2.1 to 3.4) after bleeding, and this association was consistent in participants treated with or without PCI for their index ACS (p for interaction = 0.240). The time-related association between post-discharge bleeding and mortality was similar to the association between MI and subsequent mortality in participants treated with and without PCI (p for interaction = 0.696).CONCLUSIONS Post-discharge bleeding after ACS is associated with a similar increase in subsequent all-cause mortality in participants treated with or without PCI and has an equivalent prognostic impact as post-discharge MI. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a acute coronary syndrome | |
653 | a bleeding | |
653 | a mortality | |
653 | a percutaneous coronary intervention | |
653 | a randomized trial | |
700 | 1 | a Dalgaard, Frederiku Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.4 aut |
700 | 1 | a Jones, Aaron D.u Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.4 aut |
700 | 1 | a Lokhnygina, Yuliyau Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.4 aut |
700 | 1 | a James, Stefan,d 1964-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)4 aut0 (Swepub:uu)stjam367 |
700 | 1 | a Harrington, Robert A.u Stanford Univ, Dept Med, Stanford, CA 94305 USA.4 aut |
700 | 1 | a Wallentin, Lars,d 1943-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR)4 aut0 (Swepub:uu)larswall |
700 | 1 | a Steg, Philippe Gabrielu Univ Paris, AP HP, Paris, France.;INSERM U1148, Paris, France.;Imperial Coll, Royal Brompton Hosp, London, England.4 aut |
700 | 1 | a Lopes, Renato D.u Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.;Duke Univ, Sch Med, Div Cardiol, Durham, NC 27708 USA.4 aut |
700 | 1 | a Storey, Robert F.u Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.4 aut |
700 | 1 | a Goodman, Shaun G.u Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada.;Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.4 aut |
700 | 1 | a Mahaffey, Kenneth W.u Stanford Sch Med, Dept Med, Stanford Ctr Clin Res, Palo Alto, CA USA.4 aut |
700 | 1 | a Tricoci, Pierluigiu CSL Behring, Durham, NC USA.4 aut |
700 | 1 | a White, Harvey D.u Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand.4 aut |
700 | 1 | a Armstrong, Paul W.u Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada.;Univ Alberta, Div Cardiol, Edmonton, AB, Canada.4 aut |
700 | 1 | a Ohman, E. Magnusu Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.;Duke Univ, Sch Med, Div Cardiol, Durham, NC 27708 USA.4 aut |
700 | 1 | a Alexander, John H.u Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.;Duke Univ, Sch Med, Div Cardiol, Durham, NC 27708 USA.4 aut |
700 | 1 | a Roe, Matthew T.u Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.;Duke Univ, Sch Med, Div Cardiol, Durham, NC 27708 USA.4 aut |
710 | 2 | a Duke Clin Res Inst, 200 Morris St,Room 7410, Durham, NC 27701 USA.b Kardiologi4 org |
773 | 0 | t Journal of the American College of Cardiologyd : Elsevier BVg 76:2, s. 162-171q 76:2<162-171x 0735-1097x 1558-3597 |
856 | 4 | u https://doi.org/10.1016/j.jacc.2020.05.031 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-419795 |
856 | 4 8 | u https://doi.org/10.1016/j.jacc.2020.05.031 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy